“novo-nordisk” Archives

Entry Author Date Location
Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News 08/31/11 Boston
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk 08/29/11 Boston
Amylin, Lilly, Alkermes Diabetes Drug Doesn’t Match Rival in Head-to-Head Study 03/03/11 Boston
Calibra, Inspired by Inventor With Diabetes, Homes in on Cheap, Easy Way to Deliver Insulin 01/24/11 San Francisco
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug 01/21/11 San Diego
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout 01/10/11 Boston
Institute for Systems Biology Makes it Official: It’s Moving to Seattle’s South Lake Union 08/18/10 Seattle
AlloCure, With Stem Cell Therapy for Kidney Failure, Arrives in New England with New CEO 07/06/10 Boston
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test 05/21/10 Seattle
Dendreon Makes History, Microsoft Tries Open-Source Biology, an OVP IPO Is Brewing, & More Seattle-Area Life Sciences News 05/06/10 Seattle
An OVP IPO is Brewing, Allozyne Doing Fine, VLST Finds Second Partner, & More Tidbits from the OVP Tech Summit 05/04/10 Seattle
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug 03/10/10 National
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline 12/22/09 Seattle
Dendreon Grasps for $400M, ZymoGenetics Cuts 52 Jobs, Calistoga Advances at ASH, & More Seattle-Area Life Sciences News 12/10/09 Seattle
ZymoGenetics Sells Inflammatory Drug to Old Parent, Novo Nordisk, for $24M Upfront 12/08/09 Seattle
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash 11/23/09 Seattle
Lee Hood’s New Idea, Calypso Scores $50M, Novo’s Historic Mistake Pays Off for Seattle, & More Seattle-Area Life Sciences News 09/25/09 Seattle
Novo Nordisk’s Historic Mistake is Seattle’s Future Gain, Says Novo CEO 09/18/09 Seattle
CombiMatrix Reinvents Itself From Lab Toolmaker to Cancer Diagnostics Player 06/17/09 Seattle
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News 06/11/09 San Diego
Departed Amylin Co-Founder Greene Says Company in ‘Perfect Storm,’ But Confident in Management 04/13/09 San Diego
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News 04/09/09 Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News 04/07/09 Seattle
Biotech Neighbors, VLST and Novo Nordisk, Forge Alliance in Seattle’s South Lake Union 04/06/09 Seattle
UW’s Gardasil Connection Generates Windfall for Research, Tech Transfer 02/23/09 Seattle
The Show Must Go On: Invest Northwest Forges Ahead Despite Grim Biotech Climate 02/17/09 Seattle
Lenovo Buys Switchbox, Ekos Raises $12.5M, nLight Lands $10.7M, & More Seattle-Area Deals News 02/03/09 Seattle
Page 2 of 3 « previous page · next page »